Business
AstraZeneca likely to run new COVID-19 vaccine trial, CEO says, as questions emerge – Sydney Morning Herald
The company is likely to conduct an additional global vaccine trial after current studies raised questions over its level of protection.
Soriot said he didn’t expect the additional trial to hold up regulatory approvals in the UK and European Union.
Clearance from the US Food and Drug Administration may take longer because the regulator is unlikely to approve the vaccine on the basis of studies conducted elsewhere, especially given the questions over the results, he said. Authorisation in some countries is still expected before the end of the year, he said.
AstraZeneca and its CEO are facing scrutiny as the drugmaker responds to growing…
-
Noosa News24 hours agoCar discovered in search for missing mother Tayla Spies last seen in rural Queensland two months ago
-
Business23 hours agoHow your ASX shares may be impacted by US tariffs
-
Noosa News23 hours agoSunshine Coast police saturate roads and beaches this Easter
-
Noosa News21 hours agoWith The Horrors, Clown Core, a Car Crash and an Artist Inside an Hourglass on Its 2025 Lineup, Dark Mofo Is Definitely Back